Updates in Upper GI Cancers From ASCO and ASCO GI 2024 - Episode 5
Samuel Cytryn, MD, and David B. Zhen, MD, on factors for selecting nivolumab plus chemotherapy or ipilimumab in esophageal squamous cell carcinoma.